Zobrazeno 1 - 10
of 12
pro vyhledávání: '"T. J. Ettrich"'
Autor:
G. Sommerhäuser, A. Kurreck, S. Stintzing, V. Heinemann, L. Fischer von Weikersthal, T. Dechow, F. Kaiser, M. Karthaus, I. Schwaner, M. Fuchs, A. König, C. Roderburg, I. Hoyer, M. Quante, A. Kiani, S. Fruehauf, L. Müller, A. Reinacher-Schick, T. J. Ettrich, A. Stahler, D. P. Modest
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Initial systemic therapy for patients with metastatic colorectal cancer (mCRC) is usually based on two- or three-drug chemotherapy regimens with fluoropyrimidine (5-fluorouracil (5-FU) or capecitabine), oxaliplatin and/or irinotec
Externí odkaz:
https://doaj.org/article/d871b783250b4f5bb8603eb81bc83942
Autor:
L. Perkhofer, A. W. Berger, A. K. Beutel, E. Gallmeier, S. Angermeier, L. Fischer von Weikersthal, T. O. Goetze, R. Muche, T. Seufferlein, T. J. Ettrich
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Biliary tract cancer (BTC) has a high mortality. Primary diagnosis is frequently delayed due to mostly unspecific symptoms, resulting in a high number of advanced cases at the time of diagnosis. Advanced BTCs are in principle chem
Externí odkaz:
https://doaj.org/article/b7f6cf7fdec040288d37703485410762
Autor:
G. Manzini, T. J. Ettrich, M. Kremer, M. Kornmann, D. Henne-Bruns, D. A. Eikema, P. Schlattmann, L. C. de Wreede
Publikováno v:
BMC Medical Research Methodology, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Standard survival analysis fails to give insight into what happens to a patient after a first outcome event (like first relapse of a disease). Multi-state models are a useful tool for analyzing survival data when different treatme
Externí odkaz:
https://doaj.org/article/2c6c550c8b4f461f93290604ecdc2499
Publikováno v:
Die Innere Medizin.
Autor:
A. W. Berger, T. J. Ettrich, J Backhus, Jens Dreyhaupt, T Seufferlein, Daniel Schwerdel, MM Dollinger, J Meyer
Publikováno v:
DGVS Digital: BEST OF DGVS.
Publikováno v:
TumorDiagnostik & Therapie. 36:466-474
Das kolorektale Karzinom (KRK) ist die haufigste Krebserkrankung im menschlichen Gastrointestinaltrakt. Die meisten KRK entstehen aus klassischen Adenomen (= haufigste Polypenform) der Darmschleimhaut im Rahmen einer sog. Adenom-Karzinom-Sequenz im L
Publikováno v:
Der Internist. 56(9)
Personalized tumor therapy or more precisely tumor-specific therapy has now become established in routine clinical oncology. Particularly for solid tumors, the emerging knowledge about pathways and signaling networks allows the establishment of new t
Publikováno v:
Zentralblatt fur Chirurgie. 140(4)
Colorectal cancer (CRC) is the most frequent gastrointestinal tumour. Most CRC appear to arise from adenomas of the colon in a period of 10 or 15 years. The ultimately progression of benign adenomas to malignant CRC is known as the adenoma-carcinoma
Autor:
T. J. Ettrich, T. Seufferlein
Publikováno v:
Der Onkologe. 22:696-696
Publikováno v:
Zeitschrift fur Gastroenterologie. 50(4)
Enterococci are a frequent cause of nosocomial infections in gastroenterology. The increase of Enterococcus faecium infections with development of resistance to gentamicin and vancomycin as well as possible linezolid resistance require alternative an